U.S. market Closed. Opens in 2 days 3 hours 15 minutes

INXBV | Inhibrx Biosciences, Inc. Common Stock When Issued Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 12.95 - 13.95
52 Week Range 12.95 - 18.95
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 255,013
Average Volume 440,583
Shares Outstanding 14,241,200
Market Cap 198,237,504
Sector
Industry
IPO Date N/A
Valuation
Profitability
Growth
Health
P/E Ratio N/A
Forward P/E Ratio N/A
EPS N/A
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 0
Country
*Chart delayed
Analyzing fundamentals for INXBV we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see INXBV Fundamentals page.

Watching at INXBV technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on INXBV Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙